PRACTICAL MANAGEMENT OF PEDIATRIC CARDIAC ARRHYTHMIAS

Practical Management of Pediatric Cardiac Arrhythmias

Pediatric cardiac arrhythmias represent a diverse group of rhythm disturbances that range from benign, self-limited conditions to life-threatening emergencies. Effective management requires a solid understanding of cardiac electrophysiology, age-specific normal heart rates, congenital heart disease associations, and pharmacologic principles tailored to infants and children. A practical approach emphasizes prompt recognition, accurate diagnosis, and appropriate acute and long-term treatment strategies.

Overview and Epidemiology

Arrhythmias in children differ significantly from those in adults. While coronary artery disease is rare in childhood, congenital heart defects, inherited channelopathies, and postoperative complications are common contributors. Many arrhythmias in pediatric patients are supraventricular in origin, with supraventricular tachycardia (SVT) being the most frequent symptomatic tachyarrhythmia.

Age plays a crucial role in interpretation. For example, a heart rate of 160 beats per minute may be normal in a neonate but abnormal in an adolescent. Therefore, clinicians must interpret rhythm disturbances within age-appropriate reference ranges.

Common Pediatric Arrhythmias

1. Supraventricular Tachycardia (SVT)

SVT is the most common sustained arrhythmia in children. It often results from accessory pathway–mediated reentry (e.g., Wolff-Parkinson-White syndrome) or atrioventricular nodal reentry.

Acute Management:

• Assess hemodynamic stability first.

• If stable: initiate vagal maneuvers (ice to face in infants, Valsalva in older children).

• If vagal maneuvers fail: intravenous adenosine is first-line therapy.

• If unstable: synchronized cardioversion is indicated.

Long-Term Management:

• Beta-blockers are commonly used for prophylaxis.

• Catheter ablation is considered in recurrent or drug-resistant cases, especially in older children.

2. Atrial Flutter and Atrial Fibrillation

Less common in structurally normal hearts but may occur in postoperative congenital heart disease patients.

Management includes:

• Rate control (beta-blockers or calcium channel blockers in selected age groups)

• Rhythm control (antiarrhythmics or cardioversion)

• Anticoagulation assessment in prolonged episodes

3. Ventricular Tachycardia (VT)

Ventricular tachycardia is uncommon but potentially life-threatening. Causes include myocarditis, cardiomyopathy, electrolyte imbalance, and inherited channelopathies such as long QT syndrome.

Management depends on stability:

• Stable VT: antiarrhythmic therapy (e.g., amiodarone or lidocaine)

• Unstable VT: immediate synchronized cardioversion

• Pulseless VT: follow pediatric advanced life support (PALS) protocols

Long-term therapy may involve implantable cardioverter-defibrillators (ICDs) in high-risk cases.

4. Bradyarrhythmias

Sinus bradycardia is often physiological in well-conditioned adolescents but may also result from hypoxia, increased intracranial pressure, or medication effects.

Complete heart block may be congenital or postoperative.

Management includes:

• Treat reversible causes

• Temporary pacing in acute settings

• Permanent pacemaker implantation in symptomatic or persistent cases

Diagnostic Evaluation

Accurate diagnosis begins with a detailed history, including onset, triggers, associated symptoms (palpitations, syncope, chest pain), and family history of sudden cardiac death.

Key diagnostic tools include:

• 12-lead electrocardiogram (ECG)

• Holter monitoring or event recorders

• Echocardiography to assess structural heart disease

• Exercise testing in selected cases

• Electrophysiology (EP) studies for recurrent or unclear arrhythmias

Genetic testing may be considered when inherited arrhythmia syndromes are suspected.

Pharmacologic Considerations

Medication dosing in children must be weight-based and carefully monitored. Antiarrhythmic drugs may have proarrhythmic potential, and close follow-up with ECG monitoring is essential.

Commonly used medications include:

• Adenosine (acute SVT)

• Beta-blockers (e.g., propranolol)

• Amiodarone

• Flecainide (in selected patients)

• Digoxin (less commonly used today)

Drug interactions and age-specific contraindications must always be reviewed.

Non-Pharmacologic Management

Catheter ablation has become an increasingly safe and effective option for pediatric patients, particularly for SVT due to accessory pathways. Advances in three-dimensional mapping and cryoablation techniques have improved outcomes and reduced complications.

Implantable devices such as pacemakers and ICDs are used for severe bradyarrhythmias or life-threatening ventricular arrhythmias.

Lifestyle guidance is also important. Children with channelopathies may require activity modification and avoidance of QT-prolonging medications.

Emergency Management Principles

In any pediatric arrhythmia, rapid assessment of airway, breathing, circulation, and perfusion is critical. Signs of poor perfusion—hypotension, altered mental status, weak pulses—require immediate intervention. Adherence to pediatric resuscitation guidelines ensures standardized, evidence-based care.

Psychosocial and Family Considerations

Managing pediatric arrhythmias extends beyond medical treatment. Education of parents and caregivers is vital. Families should understand symptom recognition, medication adherence, and when to seek urgent care. Adolescents may require counseling regarding sports participation and lifestyle modifications.

Conclusion

Practical management of pediatric cardiac arrhythmias requires age-specific knowledge, careful clinical assessment, and a structured treatment approach. From acute stabilization to long-term rhythm control and preventive strategies, clinicians must balance safety, efficacy, and quality of life. Advances in electrophysiology, pharmacotherapy, and device therapy have significantly improved outcomes, allowing most children with arrhythmias to lead healthy and active lives with appropriate medical care.